These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Oral administration of pyridostigmine bromide and huperzine A protects human whole blood cholinesterases from ex vivo exposure to soman. Gordon RK, Haigh JR, Garcia GE, Feaster SR, Riel MA, Lenz DE, Aisen PS, Doctor BP. Chem Biol Interact; 2005 Dec 15; 157-158():239-46. PubMed ID: 16256090 [Abstract] [Full Text] [Related]
10. Behavioral toxicity of anticholinesterases in primates: chronic physostigmine and soman interactions. Blick DW, Miller SA, Brown GC, Murphy MR. Pharmacol Biochem Behav; 1993 Jul 15; 45(3):677-83. PubMed ID: 8332626 [Abstract] [Full Text] [Related]
19. Effectiveness of pyridostigmine in reversing neuromuscular blockade produced by soman. Dirnhuber P, Green DM. J Pharm Pharmacol; 1978 Jul 15; 30(7):419-25. PubMed ID: 27607 [Abstract] [Full Text] [Related]
20. Protection from lethality and behavioral incapacitation resulting from intoxication by soman (pinacolyl methylphosphonofluoridate) and treatment with atropine sulfate and 2-PAM chloride in the guinea pig, cavia porcellus. Romano JA, Terry MR, Murrow ML, Mays MZ. Drug Chem Toxicol; 1991 Jul 15; 14(1-2):21-44. PubMed ID: 1889376 [Abstract] [Full Text] [Related] Page: [Next] [New Search]